Found: 13
Select item for more details and to access through your institution.
Glucagon Receptor Signaling and Glucagon Resistance.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 13, p. 3314, doi. 10.3390/ijms20133314
- By:
- Publication type:
- Article
The Vicious Circle of Hepatic Glucagon Resistance in Non-Alcoholic Fatty Liver Disease.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 12, p. 4049, doi. 10.3390/jcm9124049
- By:
- Publication type:
- Article
Evidence of a liver–alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids.
- Published in:
- Diabetologia, 2018, v. 61, n. 3, p. 671, doi. 10.1007/s00125-017-4535-5
- By:
- Publication type:
- Article
Neprilysin Inhibition Increases Glucagon Levels in Humans and Mice With Potential Effects on Amino Acid Metabolism.
- Published in:
- Journal of the Endocrine Society, 2021, v. 5, n. 9, p. 1, doi. 10.1210/jendso/bvab084
- By:
- Publication type:
- Article
The Liver–α-Cell Axis and Type 2 Diabetes.
- Published in:
- Endocrine Reviews, 2019, v. 40, n. 5, p. 1353, doi. 10.1210/er.2018-00251
- By:
- Publication type:
- Article
In Vivo Inhibition of Dipeptidyl Peptidase 4 Allows Measurement of GLP-1 Secretion in Mice.
- Published in:
- Diabetes, 2024, v. 73, n. 5, p. 671, doi. 10.2337/db23-0848
- By:
- Publication type:
- Article
The Liver-α-Cell Axis in Health and in Disease.
- Published in:
- 2022
- By:
- Publication type:
- journal article
323-OR: SGLT2 Inhibition Promotes Myocardial Ketone Utilization in the Normal and Failing Heart.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-323-OR
- By:
- Publication type:
- Article
154-OR: Neprilysin Inhibition Increases Glucagon Levels with Possible Implications for Hepatic Amino Acid Metabolism.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-154-OR
- By:
- Publication type:
- Article
220-LB: Glucagon Promotes Hepatic Autophagy by AMPK-Mediated mTORC1 Inhibition.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-220-LB
- By:
- Publication type:
- Article
1908-P: Glucagon Receptor Expression Evaluated by Antibody-Dependent and -Independent Approaches.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1908-P
- By:
- Publication type:
- Article
62-OR: Evidence of Gut-Derived Glucagon in Man.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-62-OR
- By:
- Publication type:
- Article
1952-P: Glucagon Receptor Antagonism Increases Plasma Amino Acids and Glucagon.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1952-P
- By:
- Publication type:
- Article